Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04781517
Other study ID # LDDAFQ-PRO
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 1, 2020
Est. completion date May 1, 2023

Study information

Verified date February 2021
Source Peking University Third Hospital
Contact Weishi Li, PhD
Phone 15611908864
Email wslee@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The commonly used scales (ODI+JOA-29+VAS) lack the assessment of lumbar stiffness, and there is no scale for evaluating lumbar stiffness in China.Based on the Delphi method and the analytic hierarchy process, this study will improve and optimize the quality of life evaluation system for patients with severe degenerative lumbar disease, so as to obtain a concise, practical, and effective patient-reported outcome instrument.


Description:

Although lumbar fusion can improve function by correcting deformity,restoring spinal stability,and reducing pain, it also by intention leads to spinal stiffness which can impair function of daily activities.The commonly used scales (ODI+JOA-29+VAS) lack the assessment of lumbar stiffness.Lumbar Stiffness Disability Index (LSDI) has not been used widely, and there is no scale for evaluating lumbar stiffness in China.In addition, even if LSDI is modified, there is still an evaluation dilemma: after lumbar long-segment fixation, the pain and neurological function-related scale scores show that the quality of life is improved, while the lumbar stiffness-related scale scores show that the quality of life is reduced . So overall, is the patient's quality of life improved or decreased? Simply combining these two types of scales cannot explain clearly. This study can be roughly divided into the following 5 main steps: Step 1:Collect and sort out the dimensions and exhaustive items that affect the patients' quality of life by systematically reviewing the related literature and a qualitative interview study. Step 2: Through a cross-sectional survey and experts' meetings, the items is initially optimized, and 35-45 items will be retained. Step 3: Screen 20-25 excellent items by 2-3 rounds of Delphi method, then use the analytic hierarchy process to determine the weight of each item, so as to establish a initial PRO instrument. Step 4: Verify the reliability and validity of the initial PRO instrument, and further optimize the initial PRO instrument in order to be used in clinical practice and research. Step 5: Verify the responsiveness of the initial PRO instrument, calculate the ES, SRM, AUC and MICD values of the initial PRO instrument. Finally, a novel, concise, practical, and effective PRO instrument for use in degenerative lumbar disease patients will be established.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date May 1, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Clinical diagnosis of Lumbar Spine Degeneration - Plan for or have undergone lumbar fusion - Be willing to participate in this research Exclusion Criteria: - Combined with neurological disease such as Motor neuron disease, Progressive muscular dystrophy, Peripheral neuropathy, Spinal cord disease, et al. - Combined with severe cervical/thoracic spine disease or other diseases that seriously affect the quality of life - Suffer lumbar spine trauma after lumbar fusion - Preoperative cases exclude patients who plan for revision surgery - Be unwilling to participate in this research

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Peking University Third Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Oswestry Disability Index (ODI) Use the Oswestry Disability Index (ODI) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of ODI score is 0 and the maximum value is 50. Higher ODI scores mean a worse outcome. In 7 days before lumbar fusion
Primary The Japanese Orthopedic Association score(JOA-29) Use the Japanese Orthopedic Association score(JOA-29) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of JOA-29 score is 0 and the maximum value is 29. Higher JOA-29 scores mean a better outcome. In 7 days before lumbar fusion
Primary The novel PRO instrument Use the novel PRO instrument to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of the novel PRO instrument score is 0 and the maximum value is 100. Higher the novel PRO instrument scores mean a worse outcome. In 7 days before lumbar fusion
Primary The Oswestry Disability Index (ODI) Use the Oswestry Disability Index (ODI) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of ODI score is 0 and the maximum value is 50. Higher ODI scores mean a worse outcome. 6 months after lumbar fusion
Primary The Japanese Orthopedic Association score(JOA-29) Use the Japanese Orthopedic Association score(JOA-29) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of JOA-29 score is 0 and the maximum value is 29. Higher JOA-29 scores mean a better outcome. 6 months after lumbar fusion
Primary The novel PRO instrument Use the novel PRO instrument to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of the novel PRO instrument score is 0 and the maximum value is 100. Higher the novel PRO instrument scores mean a worse outcome. 6 months after lumbar fusion
Primary The Oswestry Disability Index (ODI) Use the Oswestry Disability Index (ODI) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of ODI score is 0 and the maximum value is 50. Higher ODI scores mean a worse outcome. 12 months after lumbar fusion
Primary The Japanese Orthopedic Association score(JOA-29) Use the Japanese Orthopedic Association score(JOA-29) to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of JOA-29 score is 0 and the maximum value is 29. Higher JOA-29 scores mean a better outcome. 12 months after lumbar fusion
Primary The novel PRO instrument Use the novel PRO instrument to assess the quality of life of Patients with lumbar degenerative diseases before lumbar fusion.The minimum value of the novel PRO instrument score is 0 and the maximum value is 100. Higher the novel PRO instrument scores mean a worse outcome. 12 months after lumbar fusion
See also
  Status Clinical Trial Phase
Recruiting NCT04140344 - The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions N/A
Completed NCT04914728 - Mini-invasive Lumbar Arthrodesis in Ambulatory N/A
Recruiting NCT05527145 - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial N/A
Completed NCT05630404 - Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block N/A
Recruiting NCT05452694 - OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
Recruiting NCT04823858 - 3Spine Lumbar Fusion Real World Evidence Study
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT03977961 - The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
Completed NCT03176303 - Study Using the SpinalStim Device Following Lumbar Fusion Surgery
Recruiting NCT06462729 - LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) Phase 1/Phase 2
Completed NCT01143324 - A Prospective, Multicenter Observational Study on MASTâ„¢ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
Active, not recruiting NCT05438719 - MOTUS Total Joint Replacement Investigational Device Exemption Study N/A
Not yet recruiting NCT05388383 - Cost-effectiveness Analysis of Robot-assisted Spinal Surgery
Completed NCT06316921 - Epidural PCA on Pain Relief After L-spine Surgery
Completed NCT03452449 - Physical Activity, Disability and Quality of Life Before and After Lumbar Spine Surgery
Terminated NCT03527966 - rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures Phase 4
Withdrawn NCT05408923 - Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery Phase 4
Terminated NCT01415908 - INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine Phase 3
Completed NCT04062942 - The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)
Completed NCT03088306 - Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients Early Phase 1